Infleqtion, UChicago, and MIT Unite to Develop Breakthrough Cancer Solutions with AI and Quantum Algorithms
CHICAGO, Sept. 13, 2023 /PRNewswire/ -- Infleqtion, the world's quantum information company, today announced that it had been awarded funding from Wellcome Leap's Quantum for Bio (Q4Bio) program with a team of renowned researchers and medical doctors at the University of Chicago (UChicago) and Massachusetts Institute of Technology (MIT). This collaborative effort aims to transform cancer care by harnessing the power of artificial intelligence (AI) and quantum algorithms to drive personalized diagnostics and treatments. Founded by the Wellcome Trust in 2020, Wellcome Leap is a U.S. non-profit that builds and executes bold, unconventional programs designed to increase the number and speed of breakthroughs in human health.
- This collaborative effort aims to transform cancer care by harnessing the power of artificial intelligence (AI) and quantum algorithms to drive personalized diagnostics and treatments.
- The team led by Infleqtion, a company with extensive experience in commercializing quantum technologies, includes leaders in quantum computing (QC), algorithm development, multimodal genomics, and clinical cancer care.
- Dr. Aram Harrow, a Professor of Physics at MIT, is a renowned quantum algorithms developer.
- Together, the team is uniquely positioned to leverage their powerful computational resources to develop quantum cancer biomarker algorithms.